Discovery

Systematic, data-driven science coverage · Saturday, August 8, 2026
The AllSci BriefSystematic R&D and deal news. Daily.
Most Read
Business

Pfizer Q2'26: Mevrometostat, tilrekimig and sigvotatug vedotin shape pipeline outlook

Pfizer Q2'26: Mevrometostat, tilrekimig and sigvotatug vedotin shape pipeline outlook
Business

Gilead Q2'26: BIC/LEN nears approval as weekly HIV pipeline expands

Gilead Q2'26: BIC/LEN nears approval as weekly HIV pipeline expands
Business

CSPC and AstraZeneca establish biologics manufacturing joint venture in China

CSPC and AstraZeneca establish biologics manufacturing joint venture in China
Business

Novo Nordisk Q2'26: ZEUS failure overshadows obesity pipeline advances

Novo Nordisk Q2'26: ZEUS failure overshadows obesity pipeline advances
Business

Mironid raises USD 46m to advance first-in-class ADPKD therapy

Mironid raises USD 46m to advance first-in-class ADPKD therapy
More from Discovery
University of Colorado renews work on CAR-phagocyte pediatric brain cancer therapy
Discovery

University of Colorado renews work on CAR-phagocyte pediatric brain cancer therapy

The University of Colorado Cancer Center has received a USD 1.28 million NIH R01 renewal from the National Cancer Institute to develop chimeric antigen...

11h agoAlbert Einstein to optimize RNA vaccine designs for pandemics with NIAID support
Discovery

Albert Einstein to optimize RNA vaccine designs for pandemics with NIAID support

Albert Einstein College of Medicine has received a USD 2.09 million NIAID award to advance RNA vaccine design against emerging viral pathogens with pandemic...

12h agoCREATE clears Australian ethics review for first-in-human in vivo CAR-T study
Development

CREATE clears Australian ethics review for first-in-human in vivo CAR-T study

Cambridge, Massachusetts-based CREATE Medicines, Inc. has received Human Research Ethics Committee (HREC) approval in Australia to begin a first-in-human...

Jul 31University of Arizona gets NIAID backing for CD4+ T cell profiling platform
Discovery

University of Arizona gets NIAID backing for CD4+ T cell profiling platform

The University of Arizona has received a USD 3.19 million R01 grant from the National Institute of Allergy and Infectious Diseases to develop a novel assay...

12h agoAstrin Bio and University of Minnesota report plasma proteomics classifier for early-stage breast cancer detection
Discovery

Astrin Bio and University of Minnesota report plasma proteomics classifier for early-stage breast cancer detection

Researchers at Saint Paul, Minnesota-based Astrin Biosciences, working with collaborators at the University of Minnesota Masonic Cancer Center, Mayo Clinic,...

Jul 31USC wins NIA funding to advance first brain-penetrant cPLA2 inhibitors for Alzheimer's
Discovery

USC wins NIA funding to advance first brain-penetrant cPLA2 inhibitors for Alzheimer's

University of Southern California has received a USD 1.67 million NIA U01 cooperative agreement to advance brain-penetrant small molecule inhibitors of...

2d agoWeill Cornell advances mitochondrial ROS inhibitors for Alzheimer's with NIA grant
Discovery

Weill Cornell advances mitochondrial ROS inhibitors for Alzheimer's with NIA grant

Weill Cornell Medicine has received a USD 4.2 million RF1 grant from the National Institute on Aging (NIA) to advance preclinical development of a class of...

2d agoRevaGenix lands USD 12.1m NIAID contract to advance AMR therapeutics
Discovery

RevaGenix lands USD 12.1m NIAID contract to advance AMR therapeutics

San Mateo, California-based RevaGenix, Inc. has received a USD 12.1 million NIAID R&D contract to advance therapeutic candidates targeting antimicrobial...

2d ago
The AllSci BriefSystematic R&D and deal news. Daily.
University of Washington secures NIH funding for AI-guided islet cell engineering
Discovery

University of Washington secures NIH funding for AI-guided islet cell engineering

University of Washington has received a USD 1.71 million NIDDK RC2 grant to develop AI-designed mini-proteins that epigenetically direct pluripotent stem...

2d agoUC Davis advances bacterial-made microRNA therapy with renewed NCI funding
Discovery

UC Davis advances bacterial-made microRNA therapy with renewed NCI funding

University of California, Davis has received a USD 1.18 million National Cancer Institute R01 renewal to advance bioengineered microRNA therapeutics for...

2d agoUNC Charlotte spinout OncoTab wins grant to advance tMUC1 TCE for pancreatic cancer
Discovery

UNC Charlotte spinout OncoTab wins grant to advance tMUC1 TCE for pancreatic cancer

OncoTab, a Charlotte, North Carolina-based biotechnology company, has received a USD 1.13 million National Cancer Institute R44 SBIR Phase II grant to...

3d agoResearchers harness pre-existing COVID-19 immunity to boost experimental cancer vaccine
Discovery

Researchers harness pre-existing COVID-19 immunity to boost experimental cancer vaccine

Researchers at Case Western Reserve University and Cleveland-based Celloram Inc. have demonstrated that a dendritic cell cancer vaccine designed to co-opt...

3d agoTumor-distal lymph nodes may preserve immune reservoir supporting checkpoint therapy in NSCLC
Discovery

Tumor-distal lymph nodes may preserve immune reservoir supporting checkpoint therapy in NSCLC

Researchers at China-based Tianjin Medical University have identified that mediastinal lymph nodes anatomically distant from the primary tumor — previously...

3d agoIntero Biosystems's intestinal organoid platform backed by SBIR
Discovery

Intero Biosystems's intestinal organoid platform backed by SBIR

Aurora, Colorado-based Intero Biosystems Inc. has received a USD 1.05 million Small Business Innovation Research (SBIR) Phase II grant from the National...

Jul 31Kite-backed study identifies inherited genetic predictors of CAR-T toxicity and expansion
Discovery

Kite-backed study identifies inherited genetic predictors of CAR-T toxicity and expansion

Researchers at Massachusetts General Hospital in Boston, working with colleagues at the Broad Institute of MIT and Harvard and Santa Monica,...

Jul 30